Lastres-Becker, I., García-Yagüe, A. J., Scannevin, R. H., Casarejos, M. J., Kügler, S., Rábano, A., & Cuadrado, A. (2016). Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease. Antioxid Redox Signal.

Lastres-Becker, Isabel, Angel J. García-Yagüe, Robert H. Scannevin, María J. Casarejos, Sebastian Kügler, Alberto Rábano, und Antonio Cuadrado. "Repurposing the NRF2 Activator Dimethyl Fumarate As Therapy Against Synucleinopathy in Parkinson's Disease." Antioxid Redox Signal 2016.

Lastres-Becker, Isabel, et al. "Repurposing the NRF2 Activator Dimethyl Fumarate As Therapy Against Synucleinopathy in Parkinson's Disease." Antioxid Redox Signal 2016.